Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13.

Autor: Reglinski M; 1Department of Respiratory Medicine, Centre for Inflammation and Tissue Repair, University College London, London, UK.; 2Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, UK., Ercoli G; 1Department of Respiratory Medicine, Centre for Inflammation and Tissue Repair, University College London, London, UK., Plumptre C; 1Department of Respiratory Medicine, Centre for Inflammation and Tissue Repair, University College London, London, UK.; 2Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, UK., Kay E; 2Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, UK., Petersen FC; 3Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway., Paton JC; 4Department of Molecular and Biomedical Science, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA Australia., Wren BW; 2Department of Pathogen Molecular Biology, London School of Hygiene and Tropical Medicine, London, UK., Brown JS; 1Department of Respiratory Medicine, Centre for Inflammation and Tissue Repair, University College London, London, UK.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2018 Oct 31; Vol. 3, pp. 53. Date of Electronic Publication: 2018 Oct 31 (Print Publication: 2018).